Published in J Chromatogr on September 10, 1982
Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients? Lancet (1993) 3.54
Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA (1996) 3.14
Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J Virol (1994) 2.00
Quantification of the degradation products of sevoflurane in two CO2 absorbants during low-flow anesthesia in surgical patients. Anesthesiology (1992) 1.84
Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector. Anal Chem (1968) 1.80
Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J Virol (1992) 1.73
Dialysis arthropathy: complication of long term treatment with haemodialysis. Br Med J (Clin Res Ed) (1986) 1.67
Electrophysiological indicator of awakening from coma. Lancet (1993) 1.61
Selection and microevolution of coat pattern are cryptic in a wild population of sheep. Mol Ecol (2012) 1.53
Compound A concentrations during sevoflurane anesthesia in children. Anesthesiology (1996) 1.52
Clinical and biochemical comparison of clorazepate and diazepam. Psychol Med (1974) 1.46
Influence of posture on plasma nitroglycerin. Br J Clin Pharmacol (1985) 1.45
Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system. Br J Pharmacol (1986) 1.43
Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect. Proc R Soc Med (1971) 1.43
Fetal corticotrophin-releasing hormone mRNA, but not phosphatidylserine-exposing microparticles, in maternal plasma are associated with factor VII activity in pre-eclampsia. J Thromb Haemost (2007) 1.43
A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med (1992) 1.42
Factors affecting chlorpromazine plasma levels in psychiatric patients. Arch Gen Psychiatry (1970) 1.42
Continuous arteriovenous haemodialysis in critically ill patients. Lancet (1988) 1.41
Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort. Atherosclerosis (1999) 1.41
Impact of new dialysis solutions on peritonitis rates. Kidney Int Suppl (2006) 1.41
Captopril renal scintigraphy in patients with hypertension and chronic renal failure. J Nucl Med (1994) 1.41
CAPD, protective against developing dialysis-associated amyloid? Nephron (1988) 1.40
Cell type-specific proteins which interact with the 5' nontranslated region of hepatitis A virus RNA. J Virol (1993) 1.40
Lipoprotein (a) in patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (1993) 1.39
Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone). Steroids (1972) 1.39
Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant (1992) 1.39
Unsafe activities of compounding pharmacists. Am J Health Syst Pharm (1995) 1.39
Dialysis-associated amyloid: systemic or local? Nephrol Dial Transplant (1989) 1.38
Uptake of disodium cromoglycate in obstructive airways disease. Clin Allergy (1973) 1.38
Natural history and course of acquired lactic acidosis in adults. DCA-Lactic Acidosis Study Group. Am J Med (1994) 1.38
Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. Int J Pharm (1999) 1.36
Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther (1973) 1.36
Plasma protein binding of chlorpromazine. J Pharm Pharmacol (1970) 1.30
Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients. Life Sci (1968) 1.29
The physiological disposition of chlorpromazine in the rat and dog. Proc Soc Exp Biol Med (1970) 1.28
Studies of delayed-action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine. Clin Pharmacol Ther (1970) 1.28
Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J Virol (1990) 1.25
Plasma concentrations in the monkey (Macaca mulatta) of six related benzodiazepines after intraperitoneal injection [proceedings]. Br J Pharmacol (1976) 1.24
Determination of two fenamates in plasma by high-performance liquid chromatography. J Pharm Sci (1980) 1.21
A multistate outbreak of Norwalk virus gastroenteritis associated with consumption of commercial ice. J Infect Dis (1991) 1.19
Treatment of lactic acidosis with dichloroacetate. N Engl J Med (1983) 1.11
Stimulus-artifact elimination in a multi-electrode system. IEEE Trans Biomed Circuits Syst (2008) 1.10
Dialysis arthropathy: amyloid or iron? Br Med J (Clin Res Ed) (1986) 1.07
Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. Br J Cancer (1998) 1.06
Genetic, antigenic and biological differences between strains of hepatitis A virus. Vaccine (1992) 1.06
Subclavian stenosis: a major complication of subclavian dialysis catheters. Nephrol Dial Transplant (1988) 1.02
Accumulation of aluminium in chronic renal failure due to administration of albumin replacement solutions. Br Med J (Clin Res Ed) (1986) 1.01
Plasma-trifluoperazine concentrations during high dose therapy. Lancet (1981) 1.01
Joint problems in patients on maintenance hemodialysis. Clin Nephrol (1982) 1.00
Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin Pharmacol Ther (1985) 1.00
Preparation and stability of indomethacin solutions. Can J Physiol Pharmacol (1982) 1.00
Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis. Clin Sci (1972) 0.99
Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. Br J Pharmacol (1971) 0.99
THe localization, metabolism and effects of drugs and toxicants in lung. Drug Metab Rev (1974) 0.99
Death and the human body in the later Middle Ages: the legislation of Boniface VIII on the division of the corpse. Viator (1981) 0.96
Symptomless acute renal transplant rejections. Occurrence six months or more after transplantation. JAMA (1978) 0.96
Analysis of hepatitis A virus translation in a T7 polymerase-expressing cell line. Arch Virol Suppl (1994) 0.94
Estimated frequency of the canine hyperuricosuria mutation in different dog breeds. J Vet Intern Med (2010) 0.94
The genetic basis of recessive self-colour pattern in a wild sheep population. Heredity (Edinb) (2009) 0.94
Chlorpromazine plasma levels and effects. Arch Gen Psychiatry (1970) 0.93
Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers. Anesthesiology (1995) 0.93
Failure of captopril to reverse the renal crisis of scleroderma. Ann Rheum Dis (1983) 0.92
Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment. Lancet (1984) 0.92
Amikacin sulfate in mares: pharmacokinetics and body fluid and endometrial concentrations after repeated intramuscular administration. Am J Vet Res (1984) 0.92
An innovative cold tail-flick test: the cold ethanol tail-flick test. Anesth Analg (1995) 0.92
An FPGA-based approach to high-speed simulation of conductance-based neuron models. Neuroinformatics (2004) 0.92
Disposition of glutethimide in man. Clin Pharmacol Ther (1971) 0.92
Effect of dose and ointment application technique on nitroglycerin plasma concentrations. Pharmacotherapy (1983) 0.91
Event-related potentials--neurophysiological tools for predicting emergence and early outcome from traumatic coma. Intensive Care Med (1996) 0.91
Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. Kidney Int (1996) 0.91
Interaction of glutethimide and phenobarbitone with ethanol in man. J Pharm Pharmacol (1972) 0.91
Methods for study of fluphenazine kinetics in man. J Pharm Pharmacol (1976) 0.91
Semi-allogeneic cell hybrids stimulate HIV-1 envelope-specific cytotoxic T lymphocytes. AIDS (2000) 0.90
Letter: A note on the analysis of disodium cromoglycate (Intal) in human urine. J Pharm Pharmacol (1973) 0.90
Why do human hepatitis viruses replicate so poorly in cell cultures? FEMS Microbiol Lett (1992) 0.90
Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers. Anesthesiology (1994) 0.89
Destruction of chlorpromazine during absorption by rat intestine in vitro. Br J Pharmacol (1970) 0.89
Double-blind trial of fluphenazine decanoate. Lancet (1972) 0.88
Macroglossia and amyloidoma of the buttock: evidence of systemic involvement in dialysis amyloid. Nephron (1990) 0.88
The physiological disposition of 2(2,6-dichloroanilino)-2-imidazoline (St-155). Biochem Pharmacol (1969) 0.88
Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study. Atherosclerosis (2000) 0.88
Acute tolerance to a sedative in man. Br J Pharmacol (1970) 0.88
Pharmacokinetics of closely related benzodiazepines. Br J Clin Pharmacol (1979) 0.88
Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats. Fundam Appl Toxicol (1990) 0.88
Prevalence of intermittent claudication and risk factors for its development in patients on renal replacement therapy. Eur J Vasc Surg (1993) 0.87
Behavioural and pharmacokinetic studies in the monkey (Macaca mulatta) with diazepam, nordiazepam and related 1,4-benzodiazepines. Br J Pharmacol (1977) 0.87
Is the renin-angiotensin-aldosterone system involved in the sodium retention in the nephrotic syndrome? Nephron (1982) 0.87
Cholesterol emboli syndrome--uncommon or unrecognized? J R Soc Med (1997) 0.87
Theoretical changes in drug distribution resulting from changes in binding to plasma proteins and to tissues. J Pharm Pharmacol (1970) 0.87
Proceedings: Clinical pharmacology of chlorpromazine. Br J Pharmacol (1972) 0.87
Plasma-fluphenazine concentrations after injection of long-acting esters. Lancet (1978) 0.86
Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis. Nephrol Dial Transplant (1992) 0.86
Patients surviving more than 10 years on haemodialysis. The natural history of the complications of treatment. Nephrol Dial Transplant (1998) 0.86
Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection. J Pharm Pharmacol (1986) 0.85
Problems in home monitoring of blood glucose. Postgrad Med J (1980) 0.85